Back

Beyond NT-proBNP: novel biomarkers enhance short- and intermediate-term risk prediction in tricuspid valve interventions

1 September 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Valve modalities Tricuspid Valve Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Christoph Edlinger

Salzburg university hospital, Salzburg (Austria)

6 More presentations in this session

Presentation thumbnail
Reversible ventricular dysfunction in rheumatic fever reactivation: insights from imaging and corticosteroid therapy
Doctor M. Lopes (Sao Paulo, BR) Doctor V. Emer Egypto Rosa (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Hemodynamic responses to exercise and predictors of exercise capacity in patients with mitral stenosis: exercise catheterization study
Doctor S. Bang (Seoul, KR)
Abstract Slides
Presentation thumbnail
Impact of tricuspid regurgitation on activities of daily life and dementia in patients with heart failure -insight from the KUNIUMI registry chronic cohort-
Mr T. Nagano (Kobe, JP)
Abstract Slides
Presentation thumbnail
Right atrial-to-right ventricular area ratio: prognostic value in patients with secondary tricuspid regurgitation
Doctor C. Jantsch (Vienna, AT)
Abstract Slides
Presentation thumbnail
Localised hypertrophy of the basal inferolateral wall of the left ventricle is common in women with Marfan syndrome and mitral valve prolapse and is associated with prognosis
Doctor O. Milleron (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Valve modalities

The Event

Event poster

ESC Congress 2025

1 September 2025 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources